The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
- 24 October 2005
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 102 (44), 16013-16018
- https://doi.org/10.1073/pnas.0500090102
Abstract
Our understanding of pathways leading to antitumor immunity may depend on an undistorted knowledge of the primary antigenic targets of patients' autologous T cell responses. In the melanoma model derived from patient DT, we applied cryopreserved short-term autologous mixed lymphocyte–tumor cell cultures (MLTCs) in combination with an IFN-γ enzyme-linked immunospot (ELISPOT) assay to cDNA expression screening. We identified three previously unknown peptides processed from melanosomal proteins tyrosinase (presented by HLA-A*2601 and -B*3801) and gp100 (presented by HLA-B*07021) and five neoantigens generated by somatic point mutations in the patient's melanoma. The mutations were found in the genes SIRT2, GPNMB, SNRP116, SNRPD1, and RBAF600. Peptides containing the mutated residues were presented by HLA-A*03011, -B*07021, and -B*3801. Mutation-induced functional impairment was so far demonstrated for SIRT2. Within MLTC responder populations that were independently expanded from the patient's peripheral blood lymphocytes of different years, T cells against mutated epitopes clearly predominated. These results document a high degree of individuality for the cellular antitumor response and support the need for individualizing the monitoring and therapeutic approaches to the primary targets of the autologous T cell response, which may finally lead to a more effective cancer immunotherapy.Keywords
This publication has 41 references indexed in Scilit:
- Regulating self-tolerance by deregulating gene expressionCurrent Opinion in Immunology, 2004
- Immunotherapy: Bewitched, Bothered, and Bewildered No MoreScience, 2004
- Point Mutation in Essential Genes with Loss or Mutation of the Second AlleleThe Journal of Experimental Medicine, 2001
- A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutationEuropean Journal of Immunology, 1999
- Identification of GP100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primaryin vitro immunization with peptide-pulsed dendritic cellsInternational Journal of Cancer, 1998
- Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 1997
- Germline mutations in the p16INK4a binding domain of CDK4 in familial melanomaNature Genetics, 1996
- Characterization of two Epstein‐Barr virus epitopes restricted by HLA‐B7European Journal of Immunology, 1995
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993
- Individually distinct transplantation antigens of chemically induced mouse tumorsImmunology Today, 1988